Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

Based on the first favourable results of adjuvant therapy of 5FU plus levamisole in Dukes C colonic cancer in 1990, we conducted a prospective trial. 1029 patients were randomised to receive one year 5FU plus levamisole or no further treatment following curative surgery for stage II or III colon (n...

Descripción completa

Detalles Bibliográficos
Autores principales: Taal, B G, Van Tinteren, H, Zoetmulder, F A N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363941/
https://www.ncbi.nlm.nih.gov/pubmed/11720425
http://dx.doi.org/10.1054/bjoc.2001.2117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363941/
https://www.ncbi.nlm.nih.gov/pubmed/11720425
http://dx.doi.org/10.1054/bjoc.2001.2117

Ejemplares similares